Back
Altimmune, Inc. ALT · Insights
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for o... Price2.12
Market Cap435.28 M
Float204.95 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro